BioMarin Pharmaceutical | BMRN - PE Price to Earnings

Stock Price
51.21
Daily Change
-0.60 -1.16%
Monthly
-6.69%
Yearly
-13.80%
Q2 Forecast
50.77

BioMarin Pharmaceutical reported 15.28 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amgen 19.84 5.47 Mar/2026
Bayer 3.4 8.75 Mar/2026
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 28.09 807.38 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
Sanofi 15.75 1.53 Dec/2025
Sarepta Therapeutics 27.27 0 Dec/2025
United Therapeutics 20.42 3.1 Mar/2026
Vertex Pharmaceuticals 25.82 0.33 Mar/2026